All Duke Human Vaccine Institute articles
-
NewsA trial HIV vaccine triggered elusive and essential antibodies in humans
An HIV vaccine candidate triggered low levels of an elusive type of broadly neutralizing HIV antibodies among a small group of people enrolled in a 2019 clinical trial.
-
NewsGPS-like system shows promise as HIV vaccine strategy to elicit critical antibodies
Researchers have developed a vaccine approach that works like a GPS, guiding the immune system through the specific steps to make broadly neutralizing antibodies against HIV.
-
NewsScientists spot an ultra-fast movement on surface of HIV virus
Investigators catch ultra-fast HIV docking mechanism in the act, giving them a new handle on the surface of the virus that could lead to broadly neutralizing antibodies for an AIDS vaccine.
-
NewsSingle vaccine protects against three deadly strains of coronavirus
A vaccine designed to protect against three different deadly coronaviruses shows success in mouse studies.
